Skip to main content

Table 1 Participant and device characteristics

From: Health-related quality of life and experience measures, to assess patients’ experiences of peripheral intravenous catheters: a secondary data analysis

 

EQ5D-5L T0 (N=685)

EQ5D-5L T1 (N=526)

FACIT (N=264)

AHPEQS (N=262)

PARTICIPANT CHARACTERISTICS

N(%)a

N(%)a

N(%)a

N(%)a

Age (in years) (mean, SD) Range 18-99

61, 16.1

62, 15.7

61.8, 16.2

62, 15.2

Hospital

 Site 1

607 (89)

497 (94)

235 (89)

262 (100)

 Site 2

78 (11)

29 (6)

29 (11)

0 (0)

Gender (male)

454 (66)

354 (67)

174 (66)

181 (69)

Reason for admission

 Surgical

623 (91)

501 (95)

242 (92)

259 (99)

 Medical

62 (9)

25 (5)

22 (8)

3 (1)

Multiple insertion attempts (yes)

145 (21)

(n=524) 103 (20)

(n=263) 53 (20)

(n=261) 49 (19)

 Two

105 (72)

76 (74)

35 (66)

40 (82)

 Three or more

40 (28)

27 (26)

18 (34)

9 (18)

Ultrasound used (yes)

10 (1)

7 (1)

7 (1)

0 (0)

DEVICE CHARACTERISTICS

N =679

N =526

N =264

N =262

PIVC type inserted

 Integrated

323 (48)

247 (47)

123 (47)

124 (47)

 Non-integrated

356 (52)

279 (53)

141 (53)

138 (53)

Gauge size

 22/24 gauge

495 (73)

399 (76)

203 (77)

195 (74)

 20 gauge

176 (26)

121 (23)

55 (21)

67 (26)

 16/18 gauge

8 (1)

6 (1)

6 (2)

0 (0)

Device location

 Forearm

464 (68)

371 (71)

167 (63)

204 (78)

 Hand/Wrist

115 (17)

83 (16)

51 (19)

32 (12)

 Antecubital

82 (12)

61 (12)

38 (14)

23 (9)

 Other

18 (3)

11 (2)

8 (3)

3 (1)

OUTCOMES

 Dwell time (mean, SD)

2.7, 1.6

3.1, 1.5

3.0, 1.4

3.2, 1.5

 Insertion Pain (NRS 0-10) (mean, SD)

2.6, 2.3

2.6, 2.3

2.7, 2.3

2.6, 2.3

All-cause failure

196 (29)

155 (30)

87 (33)

68 (26)

Complications:b

 Infiltration

46 (7)

40 (8)

17 (6)

23 (9)

 Occlusion

22 (3)

18 (3)

12 (5)

6 (2)

 Phlebitis

101 (15)

73 (14)

45 (17)

28 (11)

 Dislodgement/leaking

60 (9)

50 (10)

27 (10)

23 (1)

 Unknown

3 (<1)

0 (0)

2 (<1)

0 (0)

Serious adverse event

 Bloodstream infectionc

5 (1)

5 (1)

1 (<1)

4 (2)

  1. aUnless otherwise noted; bmore than one option possible; EuroQol Five Dimension, Five Level = EQ5D-5L; T0 = baseline timepoint; T1 = follow-up timepoint; Australian Hospital Patient Experience Question Set = AHPEQS; Functional Assessment of Chronic Illssness Therapy – Treatment Satisfaction – General measure = FACIT-TS-G; PIVC = Peripheral Intravenous sCatheter; SD Standard deviation, NRS Numerical rating scale; cunrelated to the PIVC